Showing results (191-200 of 444) with videos related to
Sort By:
Pageof 45
Lancet (London, England)|April 8, 2017
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trialJørgen Vestbo, Alberto Papi, Massimo Corradi, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|February 25, 2003
Small airway morphology and lung function in the transition from normality to chronic airway obstructionAngelo Corsico, Manlio Milanese, Simonetta Baraldo, et al.Frontiers in Immunology|November 4, 2021
Air Pollution Exposure Impairs Airway Epithelium IFN-β Expression in Pre-School ChildrenMatteo Bonato, Elisa Gallo, Martina Turrin, et al.European Journal of Internal Medicine|May 21, 2021
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseasesAlvar Agusti, Leonardo M Fabbri, Eugenio Baraldi, et al.The Journal of Allergy and Clinical Immunology|April 13, 2010
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary diseaseJohn A Marwick, Gaetano Caramori, Paolo Casolari, et al.Lancet (London, England)|September 7, 2016
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trialDave Singh, Alberto Papi, Massimo Corradi, et al.Expert Review of Clinical Immunology|July 20, 2023
Update on virus-induced asthma exacerbationsFrancesca Urbani, Marianna Cometa, Chiara Martelli, et al.Respiratory Research|January 22, 2021
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness studyHelgo Magnussen, Sarah Lucas, Therese Lapperre, et al.The European Respiratory Journal|September 8, 2018
Inhaled corticosteroids in COPD: friend or foe?Alvar Agusti, Leonardo M Fabbri, Dave Singh, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 17, 2024
Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk QuestionnaireBradley E Chipps, Robert S Zeiger, David A Beuther, et al.Pageof 45